Year-End Report — BIOGEN for BIOGEN (2007)

Firm

BIOGEN

Client

BIOGEN

Income

—

Expenses

$620,000

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent reform (H.R. 1908 and S. 1145)

Lobbyist	Covered position, as disclosed
ADAM GLUCK	N/A
KATHLEEN TREGONING	STAFF, HEALTH SUBCOMMITTEE WAYS & MEANS CTE

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Health Issues HCR

Follow On Biologics Legislation (HR 1956, HR 1038, S. 1695) and Comparative Effectiveness

Lobbyist	Covered position, as disclosed
ADAM GLUCK	N/A
KATHLEEN TREGONING	STAFF, HEALTH SUBCOMMITTEE WAYS & MEANS CTE

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1038 (110th), S. 1695 (110th), H.R. 1956 (110th)

Medicare/Medicaid MMM

Proposal for payment of radiopharmaceuticals; comparative effectiveness

Lobbyist	Covered position, as disclosed
ADAM GLUCK	N/A
KATHLEEN TREGONING	STAFF, HEALTH SUBCOMMITTEE WAYS & MEANS CTE

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.